A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale
2008 ◽
Vol 155
(4)
◽
pp. 600-608
◽
2015 ◽
Vol 183
◽
pp. 149-155
◽
1998 ◽
Vol 3
(3)
◽
pp. 209-216
◽
2020 ◽
Vol 36
(2)
◽
pp. 255
2012 ◽
Vol 15
(3)
◽
pp. 185
◽
2012 ◽
Vol 26
(2)
◽
pp. 251-257
◽